Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors - Contacts and Locations

Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors

This study is currently recruiting participants.

Study NCT00703638. Last updated on September 22, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00703638

Locations


United States, Minnesota
	Masonic Cancer Center at University of Minnesota	Recruiting
	Minneapolis, Minnesota, United States, 55455
	Contact: Clinical Trials Office - Masonic Cancer Center at University o 612-624-2620

Sponsors and Collaborators

Masonic Cancer Center, University of Minnesota

National Cancer Institute (NCI)

Investigators


Principal Investigator:	Priya Kumar, MD	Masonic Cancer Center, University of Minnesota